• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超重 14 岁川崎病患儿静脉注射免疫球蛋白治疗的经验:病例报告。

Experience of IVIG Treatment in an Overweight 14-year-old Child With Kawasaki Disease: A Case Report.

出版信息

J Pediatr Health Care. 2024 Jul-Aug;38(4):624-628. doi: 10.1016/j.pedhc.2023.10.004. Epub 2023 Oct 25.

DOI:10.1016/j.pedhc.2023.10.004
Abstract

Kawasaki disease, or mucocutaneous lymph node syndrome, is an acute systemic vasculitis involving small and medium-sized vessels. It can be complicated by varying degrees of cardiac damage, especially coronary artery disease. The disease mainly occurs in children aged < 5 years, with rarer cases in older children and adults. Intravenous immunoglobulin combined with aspirin is the widely accepted treatment regimen in the acute phase, but the dosage recommended by the American Heart Association guidelines is not suitable for heavier children. This article reports the successful management of an overweight 14-year-old child with Kawasaki disease.

摘要

川崎病,又称黏膜皮肤淋巴结综合征,是一种累及小、中血管的急性全身性血管炎。它可并发不同程度的心脏损害,特别是冠状动脉疾病。该疾病主要发生于<5 岁儿童,在大龄儿童和成人中较少见。静脉注射免疫球蛋白联合阿司匹林是急性期广泛接受的治疗方案,但美国心脏协会指南推荐的剂量并不适用于体重大的儿童。本文报告了成功管理一名超重 14 岁川崎病患儿的案例。

相似文献

1
Experience of IVIG Treatment in an Overweight 14-year-old Child With Kawasaki Disease: A Case Report.超重 14 岁川崎病患儿静脉注射免疫球蛋白治疗的经验:病例报告。
J Pediatr Health Care. 2024 Jul-Aug;38(4):624-628. doi: 10.1016/j.pedhc.2023.10.004. Epub 2023 Oct 25.
2
Intravenous immunoglobulin for the treatment of Kawasaki disease.静脉注射免疫球蛋白治疗川崎病。
Cochrane Database Syst Rev. 2023 Jan 25;1(1):CD014884. doi: 10.1002/14651858.CD014884.pub2.
3
Intravenous Immunoglobulin Alone for Coronary Artery Lesion Treatment of Kawasaki Disease: A Randomized Clinical Trial.静脉注射免疫球蛋白单药治疗川崎病冠状动脉病变:一项随机临床试验。
JAMA Netw Open. 2025 Apr 1;8(4):e253063. doi: 10.1001/jamanetworkopen.2025.3063.
4
Incomplete Kawasaki disease presenting primarily with cough: a case report and brief literature review.主要以咳嗽为表现的不完全川崎病:一例报告及文献简要综述
BMC Pediatr. 2025 Aug 20;25(1):632. doi: 10.1186/s12887-025-05957-2.
5
Corticosteroids for the treatment of Kawasaki disease in children.用于治疗儿童川崎病的皮质类固醇。
Cochrane Database Syst Rev. 2017 Jan 27;1(1):CD011188. doi: 10.1002/14651858.CD011188.pub2.
6
Salicylate for the treatment of Kawasaki disease in children.用于治疗儿童川崎病的水杨酸盐。
Cochrane Database Syst Rev. 2006 Oct 18;2006(4):CD004175. doi: 10.1002/14651858.CD004175.pub2.
7
Overcoming the Challenges of Intravenous Immunoglobulin Resistance in Kawasaki Disease: A Case Report.克服川崎病中静脉注射免疫球蛋白抵抗的挑战:一例报告
JNMA J Nepal Med Assoc. 2024 Dec;62(280):844-846. doi: 10.31729/jnma.8837. Epub 2024 Dec 31.
8
Intravenous immunoglobulin for the treatment of Kawasaki disease in children.静脉注射免疫球蛋白治疗儿童川崎病。
Cochrane Database Syst Rev. 2003;2003(4):CD004000. doi: 10.1002/14651858.CD004000.
9
Clinical value of combined detection of serum ferritin and N-terminal pro-brain natriuretic peptide in the assessment of Kawasaki disease in children over 1 year of age.血清铁蛋白与N末端脑钠肽前体联合检测在1岁以上儿童川崎病评估中的临床价值
Ital J Pediatr. 2025 Jul 15;51(1):229. doi: 10.1186/s13052-025-02076-7.
10
Biomarkers and Related Factors for the Diagnosis, Risk of Coronary Artery Lesions, and Resistance to Intravenous Immunoglobulin in Kawasaki Disease: An Umbrella Review of Meta-Analyses.川崎病冠状动脉病变诊断、风险及静脉注射免疫球蛋白抵抗的生物标志物及相关因素:一项Meta分析的伞状综述
Pediatr Cardiol. 2024 Jul 9. doi: 10.1007/s00246-024-03563-0.